Company profile for RelonChem

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

RelonChem Limited is an independent generic pharmaceutical company delivering high-quality, own-label medicines to the UK healthcare market. With more than 400 product licences, our portfolio spans anti-diabetic, anti-hypertensive, anti-depressant, anti-cancer, anti-ulcerative, anti-viral, allergy, and pain-relief therapies. Supported by a state-of-the-art R&D laboratory, RelonChem is committed to innovation and developing pro...
RelonChem Limited is an independent generic pharmaceutical company delivering high-quality, own-label medicines to the UK healthcare market. With more than 400 product licences, our portfolio spans anti-diabetic, anti-hypertensive, anti-depressant, anti-cancer, anti-ulcerative, anti-viral, allergy, and pain-relief therapies. Supported by a state-of-the-art R&D laboratory, RelonChem is committed to innovation and developing products that meet the evolving needs of patients and healthcare partners.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Cheshire House, Gorsey Lane, Widnes Cheshire WA8 0RP
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.capitalmarket.com/markets/news/corporate-news/Relonchem-receives-UK-MHRAs-marketing-approval-for-two-products/1656545

CAPITALMARKET
17 Nov 2025

https://www.indianpharmapost.com/news/marksans-pharmas-uk-arm-relonchem-secures-mhra-nod-for-exemestane-25mg-tablets-18159

INDPHARMAPOST
06 Nov 2025

https://www.indianpharmapost.com/news/uk-relonchem-receives-marketing-authorization-for-levonorgestrel-15-mg-tablets-15976

#N/A
06 Aug 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty